{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T02:44:50Z","timestamp":1752461090626,"version":"3.32.0"},"reference-count":22,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.2176\/jns-nmc.2024-0134","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:30:51Z","timestamp":1735079451000},"page":"413-419","source":"Crossref","is-referenced-by-count":1,"title":["Two Postmortem Cases of Moyamoya Disease with Different RNF213 p.R4810K Variant Statuses"],"prefix":"10.2176","volume":"11","author":[{"given":"Tomo","family":"KINOSHITA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"TAMADA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"HARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"MUKAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"SHINTAKU","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"INAJI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"TANAKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"NARIAI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"MAEHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fujimura M, Tominaga T, Kuroda S, et al.: 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. <i>Neurol Med Chir (Tokyo)<\/i> 62: 165-170, 2022","DOI":"10.2176\/jns-nmc.2021-0382"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kuroda S, Fujimura M, Takahashi J, et al.: Diagnostic criteria for Moyamoya disease - 2021 revised version. <i>Neurol Med Chir (Tokyo)<\/i> 62: 307-312, 2022","DOI":"10.2176\/jns-nmc.2022-0072"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Berry JA, Cortez V, Toor H, Saini H, Siddiqi J: Moyamoya: an update and review. <i>Cureus<\/i> 12: e10994, 2020","DOI":"10.7759\/cureus.10994"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ihara M, Yamamoto Y, Hattori Y, et al.: Moyamoya disease: diagnosis and interventions. <i>Lancet Neurol<\/i> 21: 747-758, 2022","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kobayashi H, Matsuda Y, Hitomi T, et al.: Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis in vitro and in vivo. <i>J Am Heart Assoc<\/i> 4: e002146, 2015","DOI":"10.1161\/JAHA.115.002146"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hara S, Mukawa M, Akagawa H, et al.: Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients. <i>J Neurosurg Pediatr<\/i> 29: 48-56, 2022","DOI":"10.3171\/2021.7.PEDS21250"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Miyatake S, Miyake N, Touho H, et al.: Homozygous c.14576G&gt;A variant of RNF213 predicts the early-onset and severe form of moyamoya disease. <i>Neurology<\/i> 78: 803-810, 2012","DOI":"10.1212\/WNL.0b013e318249f71f"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Bao XY, Tong HY, Wang QN, et al.: A long-term study of posterior circulation changes after revascularization in patients with moyamoya disease. <i>J Neurosurg<\/i> 139: 1281-1286, 2023","DOI":"10.3171\/2023.2.JNS222649"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mineharu Y, Takagi Y, Koizumi A, et al.: Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group. <i>J Neurosurg<\/i> 136: 1005-1014, 2021","DOI":"10.3171\/2021.3.JNS203913"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ishigami D, Miyawaki S, Imai H, et al.: RNF213 p.Arg4810Lys heterozygosity in Moyamoya disease indicates early onset and bilateral cerebrovascular events. <i>Transl Stroke Res<\/i> 13: 410-419, 2022","DOI":"10.1007\/s12975-021-00956-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mukawa M, Nariai T, Inaji M, et al.: First autopsy analysis of a neovascularized arterial network induced by indirect bypass surgery for Moyamoya disease: case report. <i>J Neurosurg<\/i> 124: 1211-1214, 2016","DOI":"10.3171\/2015.4.JNS15155"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mukawa M, Nariai T, Matsushima Y, et al.: Long-term follow-up of surgically treated juvenile patients with Moyamoya disease. <i>J Neurosurg Pediatr<\/i> 10: 451-456, 2012","DOI":"10.3171\/2012.8.PEDS11539"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takahashi K, Nakamura J, Sakiyama S, et al.: A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous RNF213 mutation. <i>Respir Med Case Rep<\/i> 29: 100977, 2019","DOI":"10.1016\/j.rmcr.2019.100977"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ye F, Niu X, Liang F, et al.: RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. <i>Brain<\/i> 146: 4674-4689, 2023","DOI":"10.1093\/brain\/awad225"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zhang Q, Liu Y, Zhang D, et al.: RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. <i>J Neurosurg<\/i> 126: 1106-1113, 2017","DOI":"10.3171\/2016.2.JNS152173"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mukawa M, Nariai T, Matsushima Y, Ohno K: Clinical features of familial juvenile cases of moyamoya disease: analysis of patients treated in a single institute over a 28-year period. <i>J Neurosurg Pediatr<\/i> 12: 175-180, 2013","DOI":"10.3171\/2013.4.PEDS12420"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Funaki T, Takahashi JC, Takagi Y, et al.: Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. <i>J Neurosurg Pediatr<\/i> 12: 626-632, 2013","DOI":"10.3171\/2013.9.PEDS13111"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kuroda S, Kashiwazaki D, Akioka N, et al.: Specific shrinkage of carotid forks in Moyamoya disease: a novel key finding for diagnosis. <i>Neurol Med Chir (Tokyo)<\/i> 55: 796-804, 2015","DOI":"10.2176\/nmc.oa.2015-0044"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Choi EH, Lee H, Chung JW, et al.: Ring finger protein 213 variant and plaque characteristics, vascular remodeling, and hemodynamics in patients with intracranial atherosclerotic stroke: a high-resolution magnetic resonance imaging and hemodynamic study. <i>J Am Heart Assoc<\/i> 8: e011996, 2019","DOI":"10.1161\/JAHA.119.011996"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nomura S, Akagawa H, Yamaguchi K, et al.: Difference in clinical phenotype, mutation position, and structural change of RNF213 rare variants between pediatric and adult Japanese patients with Moyamoya disease. <i>Transl Stroke Res<\/i> 15: 1142-1153, 2024","DOI":"10.1007\/s12975-023-01194-w"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ruan X, Lei T, Xiang X, et al.: Insights on Moyamoya disease: vascular inflammation and nuclear autoschizis in cranial arteries. <i>Stroke<\/i> 55: e5-e7, 2024","DOI":"10.1161\/STROKEAHA.123.045064"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Thamamongood T, Hara S, Akagawa H, et al.: Synergistic interaction of thyroid autoantibodies and ring finger protein 213 variant in Moyamoya disease. <i>Neurol Med Chir (Tokyo)<\/i> 64: 43-49, 2024","DOI":"10.2176\/jns-nmc.2023-0169"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/11\/0\/11_2024-0134\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:17:17Z","timestamp":1735363037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/11\/0\/11_2024-0134\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":22,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0134","relation":{},"ISSN":["2188-4226"],"issn-type":[{"type":"electronic","value":"2188-4226"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"article-number":"2024-0134"}}